此页面上的某些内容不提供英文版本,默认显示为当前可用的语言。

Cyanine7 NHS ester

目录号 数量 价格 提前通知时间
15020 1 mg $125 现货
25020 5 mg $260 现货
45020 25 mg $510 现货
55020 50 mg $895 现货
65020 100 mg $1490 现货
Found better price? Let us know and we will propose the way forward!

Amine reactive Cyanine7, near infrared fluorescent dye, an improved analog of Cy7®.

NIR fluorophores can be used to take advantage of near infrared window of biological tissues - increased transparency of tissues in this spectral region allows to carry out in vivo imaging.

This reagent can be utilized to produce Cyanine7-labeled biomolecules for subsequent use in various in vivo research, and drug design related experiments.

The structure of Cyanine7 features rigidized design of central polymethyne chain. This molecular reinforcement allows to increase quantum yield by 20% compared with parent structure, increasing fluorescence brightness.

This reagent requires organic co-solvent for the labeling (please see Recommended Protocols section below). Water-soluble Cyanine7 NHS ester is also available, and recommended for protein NIR labeling.

顾客还购买了这个产品

Cyanine5 carboxylic acid

Cyanine5 carboxylic acid, unactivated dye.

BDP TR azide

BDP TR is a red-emitting fluorophore for the ROX channel. This is an azide for copper-catalyzed and copper-free сlick chemistry conjugation.

Cyanine5.5 NHS ester

Cyanine5.5 NHS is far-red / near-infrared amine-reactive dye.
将此产品添加到购物车中
并获得免费的快递服务

General properties

Appearance: dark green solid
Molecular weight: 733.64
CAS number: 2408482-09-5
Molecular formula: C41H48N3BF4O4
Solubility: soluble in organic solvents (DMSO, DMF, dichloromethane), low solubility in water
Quality control: NMR 1H, HPLC-MS (95%)
Storage conditions: Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
安全数据表(MSDS): 下载
产品规格

Spectral properties

Excitation/absorption maximum, nm: 750
ε, L⋅mol−1⋅cm−1: 199000
Emission maximum, nm: 773
Fluorescence quantum yield: 0.3
CF260: 0.022
CF280: 0.029

产品引用

  1. Ehrman, R.N.; Brohlin, O.R.; Wijesundara, Y.H.; Kumari, S.; Trashi, O.; Howlett, T.S.; Trashi, I.; Herbert, F.C.; Raja, A.; Koirala, S.; Tran, N.; Al-Kharji, N.M.; Tang, W.; Senarathna, M.C.; Hagge, L.M.; Smaldone, R.A.; Gassensmith, J.J. A scalable synthesis of adjuvanting antigen depots based on metal–organic frameworks. Chemical Science, 2024, 15(8), 2731-2744. doi: 10.1039/d3sc06734c
  2. Seo, H.S.; Han, J.-H.; Lim, J.; Bae, G.-H.; Byun, M.J.; Wang, C.-P.J.; Han, J.; Park, J.; Park, H.H.; Shin, M.; Park, T.-E.; Kim, T.-H.; Kim, S.-N.; Park, W.; Park, C.G. Enhanced Post-Surgical Cancer Treatment Using Methacrylated Glycol Chitosan Hydrogel for Sustained DNA/Doxorubicin Delivery and Immunotherapy. Biomaterials Research, 2024, 28, 0008. doi: 10.34133/bmr.0008
  3. Ehrman, R. N.; Brohlin, O. R.; Wijesundara, Y. H.; Kumari, S.; Trashi, I.; Trashi, O.; Howlett, T. S.; Herbert, F. C.; Raja, A.; Koirala, S.; Tran, N.; Al-Kharji, N. M.; Hagge, L. M.; Gassensmith, J. A Scalable Synthesis of Adjuvanting Antigen Depots Based on Met-al-Organic Frameworks. ChemRxiv, 2023, preprint. doi: 10.26434/chemrxiv-2023-gtl30
  4. Itzhaki, E.; Chausky-Barzakh, E.; Atkins, A.; Bareket-Samish, A.; Stemmer, S. M.; Margel, S.; Moskovits, N. Tumor-Targeted Poly(ArgGlyAsp) Nanocapsules for Personalized Cancer Therapy – In Vivo Study. Advanced Therapeutics, 2023, 6(6), 2200337. doi: 10.1002/adtp.202200337
显示更多 (112)
您的商品已添加. 查看您的 购物车 或者 继续结账
商品数量不正确.